We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The FDA has cleared a next-generation integrated ...

As diabetes device makers race to build completely hands-off artificial pancreas systems, Abbott’s continuous glucose monitors are getting a significant upgrade. New regulatory clearance passed down ...

FreeStyle Libre is a continuous glucose monitoring (CGM) system. It uses a sensor to read and check a person’s glucose levels. People with diabetes can use FreeStyle Libre to help manage the condition ...

Traditional food logging apps offer feedback after the fact—Libre Assist1 offers help in-the-moment to inform mealtime decisions before every bite Libre Assist1 leverages AI to predict how food ...

Abbott Diabetes Care shared some real-world evidence this morning at the International Conference on Advanced Technologies & Treatments for Diabetes, bolstering clinical trial data about the ...

Abbott is taking two of its continuous glucose monitoring (CGM) technologies over the counter. The Abbott Park, IL-based company said it won nods from FDA for the Lingo and Libre Rio, based on its ...

Diabetes remains a serious chronic disease worldwide, affecting approximately 589 million people 3 and often accompanied by cardiovascular complications. 4 People with Type 1 and Type 2 diabetes are 2 ...

Abbott is honing its financial projections for the remainder of this year, nudging their average slightly higher as it reports continued growth among its core business areas—bookended by big gains in ...

It’s buff versus buffet in the latest DTC ad battle of continuous glucose monitors. While Dexcom continues its blood-sugar monitoring campaign with musician and heartthrob Nick Jonas, Abbott takes a ...

ABBOTT PARK, Ill., Jan. 5, 2026 /PRNewswire/ -- Abbott (NYSE: ABT), a leading healthcare company, today unveiled Libre Assist,1 a groundbreaking feature within the Libre app5 designed to help the ...